Novo CEO pressed by Senate to cut charges of obesity, diabetes medicine CEO Lars Fruergaard Jørgensen explained to lawmakers the organization would take into account new talks with insurers with regard to the list costs of Wegovy and copyright if they pledge to help keep the medicines on their formularies. https://paxtonrnezq.affiliatblogger.com/82774095/the-smart-trick-of-healthcare-news-that-nobody-is-discussing